WASHINGTON (DC News Now) — September is Prostate Cancer Awareness Month, and according to the National Cancer Institute (NCI), approximately one in eight men will be diagnosed with prostate cancer in ...
Favorable safety and tolerability profile with no Grade 3 or greater treatment-related adverse eventsCompany expects to complete enrollment of ...
A recent breakthrough study highlights how a simple at-home urine test could accurately detect prostate cancer. Researchers from Vanderbilt University and the University of Michigan suggest this ...
A new study led by investigators from the UCLA Health Jonsson Comprehensive Cancer Center has demonstrated a new, non-invasive imaging technique can accurately detect clear-cell renal cell carcinoma, ...
Ductal carcinoma in situ (DCIS) is a non-invasive breast condition found in nearly 20% of breast cancer diagnoses, but a growing number of doctors and medical experts are questioning whether the term ...
A local hospital is using new technology to remove liver cancer without invasive surgery.
Landmark trials have driven a shift from radical mastectomies to less invasive, breast-conserving surgeries. Non-invasive breast carcinomas, when detected early, have highly favorable survival and ...
ImmunityBio Inc. IBRX shares are up on Monday following the company’s announcement of significant revenue growth. • ...
Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor ...